The Analgesic Efficacy of Δ9-THC (Namisol®) in Patients With Persistent Postsurgical Abdominal Pain

Abstract

Authors » Radboud University Medical Center

Category » Primary study

Registry of Trials»clinicaltrials.gov

Year » 2012

Links » Registry of Trials

This article is not included in any systematic review

This article is part of the following publication threads:

Radboud University [provisional name] [THC for persistent postsurgical abdominal pain [provisional name]] (2 documents)

Loading references information

Persistent postsurgical abdominal pain (PPAP) is a very difficult to treat pain. This pain can persist for months or even years and significantly diminishes quality of life. The exact underlying cause for this pain persistence is still unclear, which makes its treatment still a challenge. The promising analgesic effects of Δ9-THC in previous research, plus the improved bioavailability of Namisol® in comparison with previous Δ9-THC substances form the basis of the present research proposal.

The current study aims to investigate the analgesic efficacy of Namisol® as add-on analgesic during a long-term treatment (52 days) of persistent postsurgical abdominal pain.

Epistemonikos ID: 2e7c7b0ae51663ed1930a3f9a973589e126246d9
First added on: Mar 22, 2018